|

E-intervention on Subclinical Fear of Cancer Recurrence

RECRUITINGN/ASponsored by The University of Hong Kong
Actively Recruiting
PhaseN/A
SponsorThe University of Hong Kong
Started2024-05-02
Est. completion2025-12-30
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06207006

Summary

The present study aims to adapt a metacognition-based ConquerFear-HK to an internet-based self-management intervention, namely eConquerFear-HK and evaluate in a randomised controlled trial, its feasibility, utility, and potential effectiveness on fear of cancer recurrence reduction among local Chinese cancer survivors with subclinical fear of cancer recurrence.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Cantonese- or Mandarin-speaking Chinese cancer survivors
* recently diagnosed with potentially curable (stage 0 to III) colorectal or breast cancer
* had recently completed surgery as primary treatment
* have completed hospital-based adjuvant treatments (including radiotherapy and chemotherapy) within the past six months
* scored 13 to 21 on the fear of cancer recurrence-short form will be recruited.

Exclusion Criteria:

* non-Chinese ethnicity
* metastatic cancer
* with current diagnosis of depression or psychosis or are currently receiving psychological treatments
* language or intellectual difficulties that prevent them from understanding the intervention content
* having limited or no Internet access.

Conditions3

CancerFear of Cancer RecurrencePsychooncology

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.